pain reduction

Showing: 1 - 1 of 1 Articles

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for …